Discernment between candidate mechanisms for KRAS G13D colorectal cancer sensitivity to EGFR inhibitors is a research paper published in Cell Communication and Signaling (2020). On theSindex it has a DataRank of 0.494. It has been cited 26 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.494
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: R01CA223495
National Cancer Institute
Grant: K22CA216318
National Cancer Institute
Grant: P30CA014195
National Cancer Institute
Grant: T32CA009370
NCI NIH HHS
Grant: L30 CA162395
National Institutes of Health
Grant: 2P30CA014195-31
Senior Leadership
National Institutes of Health
Grant: 5T32CA009370-06
CELL REGULATION DIFFERENTIATION AND CANCER
National Institutes of Health
Grant: 1K22CA216318-01
Systems Biology of RAS and RAF Oncogenes and Personalized Medicine
National Institutes of Health
Grant: 1R01CA223495-01A1
A HTS Approach to Discover Guanine Nucleotide-Competitive Inhibitors of Oncogenic KRAS
FWCI
0.61
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals